• EC2 I/O Performance Broken Down and Stranger Than Expected

    Scalyr Blog | Scalyr Blog breaks down Amazon's EC2 I/O performance with data from over 1,000 EC2 instances, $1,000 in AWS charges and billions of I/O operations. The results were stranger than they expected.

    Oct 18, 2012

  • Mainframes Considered 'Highly Strategic' Study Finds

    CA Technologies | A CA Technologies survey finds that more than 80% of IT decision makers call the mainframe a "highly strategic part of their IT plans." But  most consider it essential within the realm of their cloud plans.

    Oct 18, 2012

  • Sequencing at Scale: Pros and Cons

    NYGC | There are two opinions in sequencing: "bigger is better" and "small is best." Big sequencing centers can scale efficiently, but sometimes big centers can't meet the specific needs of users.

    Oct 17, 2012

  • Google: Behind the Curtain

    Wired | A peek into Google's top secret data center featuring a Google Street View tour and more.

    Oct 17, 2012

  • Biotech IPOs: More to be Expected?

    Forbes | Are Biotech IPOs back? Two recent offerings netted 20% above their offer price.

    Oct 17, 2012

  • Appistry to License Broad's GATK 2.0 to For Profit Users

    Bio-IT World | The Broad Institute and Appistry announced an arrangement this morning for Appistry to distribute and support the Broad’s Genome Analysis Toolkit (GATK) for next-generation sequencing data analysis. For a subscription fee, Appistry will distribute the GATK and its suite of analysis tools to for-profit users and provide commercial-grade customer support. 

    Oct 16, 2012

  • New Cancer Center Planned for Northern Virginia

    Washington Business Journal | A new comprehensive cancer center planned for Northern Virginia might be able to accomplish what Dietrich Stephan's Ignite Institue wasn't able to.

    Oct 15, 2012

  • News from Vienna: BT, Aspera, GenoLogics, CLC

    Bio-IT World | Bio-IT World Europe wrapped up in Vienna last week. A full report will follow, but first, some company announcement highlights from BT, Aspera, GenoLogics, CLC bio.

    Oct 15, 2012

  • AstraZeneca Inks Chinese Drug Discovery Partnership

    Bloomberg | AstraZeneca has partnered with Beijing-based Pharmaron to expand their R&D efforts. The partnership adds "a few hundred" researchers to AstraZeneca's team in China.

    Oct 15, 2012

  • Whole Genome Class for Medical Students

    Nature News Blog | Mount Sinai Medical School in New York is offering an elective course called ‘Practical Analysis of Your Personal Genome’ this year. The goal is to teach upcoming physicians how sequencing information might affect clinical care.

    Oct 12, 2012

  • IMPROVER-ing Data Verification for Systems Biology

    Bio-IT World | There was CASP. Then there was DREAM. And now, IMPROVER. The latest algorithm competition is tackling data verification in systems biology research. 

    Oct 12, 2012

  • GSK Releases 200 TB Compounds for Open Innovation

    PM Live | GlaxoSmithKline has released access to 200 compounds with possible action against tuberculosis in a move toward an "open innovation" approach to R&D.

    Oct 11, 2012

  • FDA Recalls Generic that Doesn't Work

    Forbes | The FDA took a generic version of Wellbutrin XL off the market yesterday because it just doesn't work--and hasn't worked for years.

    Oct 11, 2012

  • True Blood: Swiss Start-Up Biognosys Pushes Personalized Proteomics

    Bio-IT World | As biotech catchphrases go, “personalized proteomics” hasn’t quite registered as much as some, but according to Swiss biotech company Biognosys, recent advances in mass spectrometry and bioinformatics could have enormous ramifications for biomedical research, drug discovery, and even consumer health.

    Oct 10, 2012

  • Nobel Prize in Chemistry Awarded for Receptor Work

    Bio-IT World Roundup | The Nobel Prize in chemistry was awarded to two doctors for their work with G-protein-coupled receptors.

    Oct 10, 2012

  • The Intersection of Genetics and Economics

    Nature News | A paper slated to appear in the American Economic Review claims that a country's genetic diversity can predict the success of its economy. Critics worry that the paper is making claims that the inverse is also true.

    Oct 10, 2012

  • Science Prizes as Awards or Incentives

    The Guardian | With the announcement of the Nobel Prize in physics, The Guardian looks at the pros and cons of scientific awards as rewards or as incentives.

    Oct 9, 2012

  • The Prosecution RESTs

    Bio-IT World | Inside the Box Guest Column | Life Technologies has recently delivered version 3.0 of the Torrent Suite software, which includes updates to the RESTful API. Finally, in an industry chronically plagued with data integrity problems, a simple, modern API is available. 

    Oct 8, 2012

  • Health IT Company Claims 47 Second Genome Analysis

    eWeek | Health IT company NantHealth has introduced a supercomputing platform that it says can reduce the time required to analyze genomic data of a cancer patient from eight weeks to 47 seconds.

    Oct 8, 2012

  • University Medical Center Invests $100 Million in IT from IBM, Oracle

    eWeek | The University of Pittsburgh Medical Center has announced a five-year, $100 million investment in data warehousing and analytic tools incorporating IT infrastructure from dbMotion, IBM, Informatica, and Oracle.

    Oct 8, 2012